(Q37072971)

18 August 2017

1 reference

title

Ellagic acid, pomegranate and prostate cancer -- a mini review (English)

1 reference

18 August 2017

1 reference

Carolyn Bell

1

1 reference

18 August 2017

Susan Hawthorne

series ordinal

2

1 reference

18 August 2017

publication date

1 February 2008

1 reference

Journal of Pharmacy and Pharmacology

18 August 2017

published in

1 reference

18 August 2017

volume

60

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

139-144

1 reference

Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Molecular targets of dietary agents for prevention and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Clinical trials of natural products as chemopreventive agents for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Chemoprevention for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

What causes prostate cancer? A brief summary of the epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Prostate cancer risk in U.S. blacks and whites with a family history of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Dairy products, calcium and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum l.) polyphenols after ingestion of a standardized extract in healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Natural products for cancer prevention: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Tea beverage in chemoprevention of prostate cancer: a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

The complex genetic epidemiology of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

BRCA2 mutation in Icelandic prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Nutrition and prostate cancer: a proposal for dietary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.2.0001

21 January 2018

Identifiers

DOI

10.1211/JPP.60.2.0001

1 reference

18 August 2017

1 reference